引導式測驗 · 中等 等級

AI 抗生素發現測驗

測試人工智慧篩選工作流程、窄譜證據、臨床前與臨床聲明、抗藥性和後續實驗。

相關引導路徑AI 抗生素發現
問題 1 的 8

What does the abaucin study establish?

預覽每個問題8 問題

當您參加測驗時,就會出現答案和解釋。

  1. What does the abaucin study establish?
    • A clinical cure for resistant infections
    • A replacement for susceptibility testing
    • A narrow-spectrum compound with experimental activity against A. baumannii in reported models
    • A broadly effective human antibiotic
  2. What labels trained the discovery model?
    • Bacterial growth-inhibition data from screened molecules
    • Patient survival after treatment
    • Clinician ratings of infection severity
    • Drug prices in a hospital formulary
  3. Why test a predicted antibiotic hit against mammalian cells?
    • To determine its brand name
    • To prove it works in every bacterium
    • To measure how fast the model runs
    • To assess whether activity may reflect harmful nonspecific toxicity
  4. What does a mouse infection model not establish?
    • That researchers can study mechanisms
    • Human safety and clinical efficacy
    • That the compound was tested in an animal
    • That the study included a pathogen
  5. Why examine a strain panel?
    • It replaces mechanism testing
    • It proves resistance cannot emerge
    • Activity against one isolate may not generalize across strains or species
    • Every bacterial strain behaves identically
  6. What should a report include for an antibiotic discovery hit?
    • Only the neural-network architecture
    • Only a predicted score
    • The names of all unrelated compounds
    • Assay, species, strains, controls, selectivity, and evidence stage
  7. What can resistance studies help determine?
    • Whether the model was trained correctly
    • Whether bacteria can evolve reduced susceptibility to the candidate
    • Whether the molecule can be synthesized at scale automatically
    • Whether it treats viral infections
  8. When is it accurate to call an AI-selected compound a treatment?
    • Only after appropriate evidence supports its clinical use
    • As soon as an in-vitro score is high
    • After a model generates a structure
    • When a mouse result is positive